3 Life Science Stocks to Buy Now

BRKR, WAT, WX improve in weekly rankings

   
3 Life Science Stocks to Buy Now

The grades of three Life Science stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

Bruker’s (NASDAQ:BRKR) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). Bruker designs, manufactures, markets and serves proprietary life science and materials research systems based on its core technology platforms, including X-ray technologies, magnetic resonance technologies, mass spectrometry technologies, optical emission spectroscopy and infrared and Raman molecular spectroscopy technologies. In Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Revisions, Earnings Surprise, and Equity, BRKR also gets A’s. The stock price has risen 7.1% over the past month, better than the 4.4% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of BRKR stock.

Waters Corp. (NYSE:WAT) earns a B this week, jumping up from last week’s grade of C. Waters is an analytical instrument manufacturer that designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography, mass spectrometry instrument systems, and support products. Wall Street seems to agree with the upgrade and has propelled the stock up 8.6% over the past month. For more information, get Portfolio Grader’s complete analysis of WAT stock.

This week, WuXi PharmaTech (NYSE:WX) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. WuXi PharmaTech operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company primarily in the People’s Republic of China and the United States. The stock’s trailing PE Ratio is 4.90. For more information, get Portfolio Grader’s complete analysis of WX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2012/12/3-life-science-stocks-to-buy-now-brkr-wat-wx/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.